OmniAb OABI
NASDAQ OABI
$4.53 -0.22 (-4.74%)
As of: Sep 4, 2026 · 11:51 AM EDT

OmniAb (OABI) Amortization - Intangibles (2022 - 2026)

OmniAb (OABI) posted quarterly Amortization - Intangibles of $6.0 million for Q1 2026, up 88.38% year-over-year from $3.2 million in Q1 2025, and up 88.38% quarter-over-quarter from $3.2 million in Q4 2025.

Analysis

OmniAb (OABI) Amortization - Intangibles (2022 - 2026) Analysis & Trends

OmniAb (OABI) has reported Amortization - Intangibles for 5 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization - Intangibles rose 88.38% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $15.7 million (down 8.99% YoY), while the FY2025 annual figure was $12.9 million, down 25.89% from the prior year.
  • Amortization - Intangibles improved to $6.0 million in Q1 2026 per OABI's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $6.1 million in Q4 2024 and bottomed at $3.1 million in Q2 2022.
  • Historically, Amortization - Intangibles has averaged $3.7 million across 5 years, with a median of $3.4 million in 2023.
  • Annual changes were most pronounced in 2025 — Amortization - Intangibles tumbled 47.19% — and 2026, when it surged 88.38%.
  • OmniAb's Amortization - Intangibles stood at $3.3 million in 2022, then grew by 5.43% to $3.5 million in 2023, then surged by 75.42% to $6.1 million in 2024, then sank by 47.19% to $3.2 million in 2025, then soared by 88.38% to $6.0 million in 2026.
  • Business Quant data shows OABI's Amortization - Intangibles at $6.0 million in Q1 2026, $3.2 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn -
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn
10 OmniAb 582.15 Mn 530.16 Mn 12.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.10 Mn
Mar 31, 2026 6.03 Mn
Dec 31, 2025 3.21 Mn
Sep 30, 2025 3.23 Mn
Jun 30, 2025 3.23 Mn
Mar 31, 2025 3.23 Mn
Dec 31, 2024 6.06 Mn
Sep 30, 2024 3.40 Mn
Jun 30, 2024 4.54 Mn
Mar 31, 2024 3.41 Mn
Dec 31, 2023 3.45 Mn
Sep 30, 2023 3.40 Mn
Jun 30, 2023 3.40 Mn
Mar 31, 2023 3.40 Mn
Dec 31, 2022 3.25 Mn
Sep 30, 2022 3.30 Mn
Jun 30, 2022 3.11 Mn
Mar 31, 2022 3.41 Mn